Free Newsletter
Open source trial software boasts speed
Akaza Research has released the beta version of OpenClinica 3.0 clinical trial software, which now includes source data verification tools, task-oriented navigation, study dashboards, and a web services API. Akaza says the new release boasts "an order of magnitude improvement in application speed for studies with over 10,000 subjects and over 1 million data points. The open-source software is free. Announcement
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: